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INTRODUCTION
About 146 970 new cases of colorectal cancer (CRC)
and 49920 CRC deaths were expected in the U.S. in 2009
[1]. U.S. hospital admissions for CRC were projected to
increase from 205000 to 471000 among people 50 years
and older from 1992 to the year 2050 [2]. CRC thus poses
a considerable health and economic burden in the U.S.
Screening for CRC is effective and cost effective in
reducing morbidity and mortality and is recommended by
the American Cancer Society (ACS), American
Gastroenterological Association, Centers for Disease
Control and Prevention and the United States Preventive
Services Task Force (USPSTF) [3-6]. Screening
modalities recommended by the ACS for persons at
average risk aged 50 and above at the time of this study
included an annual fecal occult blood test (FOBT) or a
flexible sigmoidoscopy (FS) every 5 years, or an annual
FOBT and a FS every 5 years or a double contrast barium
enema (DCBE) every 5 years or a colonoscopy (COL)
every 10 years [3]. The Healthy People 2010 goal that “At
least 50 percent of adults aged 50 years or older who have
received a FOBT within the preceding 2 years and who
have ever received a sigmoidoscopy” were not met [7].
There is a need for interventions to increase adherence to
CRC screening (CRCS) in the target population of
average risk adults in the U.S.
Screening promotion interventions have applied the
concept of “tailoring” based on the specific attitudes,
knowledge and beliefs of the participants [8]. While
tailoring was expected to improve the behavioral
response, it added to the cost of implementing screening
promotion interventions due to the need to collect
participant specific information. It was therefore
important to inform decision makers about the cost
effectiveness of tailored interventions and the
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Objectives: Screening for colorectal cancer is considered cost effective, but is underutilized in the U.S. Information on the
efficiency of “tailored interventions” to promote colorectal cancer screening in primary care settings is limited. The paper
reports the results of a cost effectiveness analysis that compared a survey-only control group to a Centers for Disease
Control (CDC) web-based intervention (screen for life) and to a tailored interactive computer-based intervention.
Methods: A randomized controlled trial of people 50 and over, was conducted to test the interventions. The sample was
1224 partcipants 50-70 years of age, recruited from Kelsey-Seybold Clinic, a large multi-specialty clinic in Houston,
Texas. Screening status was obtained by medical chart review after a 12-month follow-up period. An “intention to treat”
analysis and micro costing from the patient and provider perspectives were used to estimate the costs and effects.
Analysis of statistical uncertainty was conducted using nonparametric bootstrapping. 
Results: The estimated cost of implementing the web-based intervention was $40 per person and the cost of the tailored
intervention was $45 per person. The additional cost per person screened for the web-based intervention compared to no
intervention was $2602 and the tailored intervention was no more effective than the web-based strategy.
Conclusions: The tailored intervention was less cost-effective than the web-based intervention for colorectal cancer
screening promotion. The web-based intervention was less cost-effective than previous studies of in-reach colorectal
cancer screening promotion. Researchers need to continue developing and evaluating the effectiveness and cost-
effectiveness of interventions to increase colorectal cancer screening.
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uncertainties associated with projecting the results of
studies to “real world” applications. Few previous
studies of CRCS promotion provide evidence on cost-
effectiveness of tailored interventions for improving
screening compliance [9-11]. Studies were needed to
assess the effectiveness and efficiency of tailored CRCS
promotion interventions [12]. The following cost
effectiveness analysis was done to determine the
efficiency of tailored and web-based interventions for
improving adherence to CRCS.
METHODS
Project PCCaSO, a randomized trial funded by the
National Cancer Institute (R01CA97263-02), was
conducted through the University of Texas Health
Science Center at Houston School of Public Health
(UTSPH) and the Kelsey Research Foundation (KRF)
[13].The study protocol was approved by the
institutional review board at UTSPH. Participants
included 1224 patients from Kelsey-Seybold Clinic
(KSC), a large multi-specialty group practice that serves
about 400 000 people in greater Houston, Texas.
Inclusion criteria were adult patients aged 50 to 70 years
who had a visit to the clinic within the past year, had no
history of CRC, and either never screened for CRC or
were currently due for screening according to the ACS
guidelines [3]. Participants were recruited to the study
between 2004 and 2006. Patients who had already
scheduled a routine physical exam within the next month
or agreed to schedule one with their primary care
provider at KSC were selected. Participants received an
invitation letter and follow-up phone calls from KRF to
confirm their participation and obtain a verbal HIPAA
authorization. Participants completed a baseline
telephone survey to gather information about
demographics, history of CRC and CRCS, and beliefs
about screening. 
Participants were randomized so that the
characteristics of the participants were distributed evenly
among the three study groups: 1) tailored interactive
computer-based intervention, 2) web-based (screen for
life) intervention and 3) survey-only control group
(Figure 1). The tailored interactive computer-based
intervention was developed and tested by the project
team using intervention mapping that utilizes empiric
evidence and theory to identify determinants of health
behavior and select strategies for an intervention [14].
The 15 to 25 minute computer-based tailored
intervention was based on the Transtheoretical Model.
The program utilized video vignettes that aimed to
identify the individual’s stage of readiness to undergo
screening, increase their knowledge about CRC, and
increase their motivation for CRC screening. The
program summarized the patient’s primary questions
about CRCS and printed a letter to serve as a basis for
discussion about CRCS with their physician during their
wellness visit. The intervention was informed by expert
systems used in previously successful interventions to
promote cancer screening [15,16]. The interactive
computer program was built using Flash MX 2004
Professional and Adobe products including Photoshop,
Illustrator, Premier, and Audition. Data were tracked and
converted from the program into a database with
MicroSoft Access. Details of the development process
and cost of developing the interactive program were
previously published [17].The web-based “Screen for
Life” program runs on the Center for Disease Control
(CDC) website, and provides information about cancer
risks and screening recommendations[18]. Participants
in this group were asked to view the website while in the
Health Information Center (HIC), prior to their medical
appointment.
Participants were asked to arrive at the HIC at KSC 45
minutes prior to their primary care appointment. The
intervention groups received their interventions prior to
their appointment, while the survey-only control group
received no intervention during the HIC visit, but could
browse through educational materials located in the HIC
or go to their appointment. The physicians were blinded
to the study assignment of their patients unless the
patients discussed their participation in the study with
their physician. A 6-month follow up telephone survey
collected data on knowledge, attitudes, and beliefs to
assess change in those factors. Patients’ medical charts
were reviewed one year after the appointment to
determine the participant’s CRCS status. 
I. Effect Estimation
The effectiveness measure was the proportion of
participants who were adherent with screening in each
group within 12 months of receiving the intervention.
The screening adherence rates for the two intervention
groups were compared with the control group and with
each other. 
II. Cost Estimation
Costs were estimated from the provider and
participant perspective for each intervention group and
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summarized by major activity, which included
recruitment, intervention delivery and 6 month follow-
up. The material and time cost for each project activity
was determined by prospective micro costing, where the
resource use was tracked and weighted with local prices.
The cost data were gathered from the following sources:
Personnel time logs for time spent in minutes for each
task of the different project activities 
Participant time log data for telephone survey
completion and intervention viewing 
Purchase orders and invoices for materials used in the
project
Estimation of overhead costs as a percentage of the
direct cost
Total cost was computed as the sum of the direct cost
for each activity plus the overhead cost. Overhead cost
was estimated at 35% of direct cost. Average cost per
participant was calculated by dividing the total cost for
each intervention by the number of participants in each
intervention group. Development cost of the tailored
intervention was not included in the analysis as it was
considered a “sunk cost.” Research costs, including the
12 month follow-up chart review were not included in
the analysis. All costs were valued in 2004 U.S. dollars,
the year that data collection was initiated.
III. Description of Costs According to
Project Activities
A. Recruitment cost 
The cost of recruiting study participants was the sum
of the time cost of personnel to: 1) identify eligible
participants from the patient database, 2) develop
Figure 1. Project PCCaSO intervention process flowchart.
HIC: health information center, CRC: colorectal cancer, HIPAA: health insurance portability and accountability act, KSC: Kelsey- Seybold clinic, 
PCP: primary care physician, CRCS: cases of colorectal cancer screening.
recruitment letters and 3) make follow-up phone calls to
enroll eligible patients and obtain consent. Personnel
time cost was calculated by multiplying the adjusted
salary per minute by the number of minutes spent on the
recruitment process [19]. Recruitment costs also
included the cost of postage, supplies and materials for
sending letters to the eligible participants. 
B. Intervention delivery and follow-up
The cost of administering the intervention at the HIC
and conducting the 6-month survey was comprised of
personnel time and overhead cost. Personnel cost was
calculated by multiplying the adjusted salary per minute
by the number of minutes spent delivering the
intervention and administering the 6 month survey.
Overhead cost included facility, office space, utilities,
equipment, computers and database management. It was
calculated by multiplying direct costs for each group
with a hypothetical overhead rate of 35% [19]. 
Time spent by the participants viewing the CRCS
information on either the website or the tailored
intervention was automatically tracked when they
logged onto the computer in the HIC. Patient time cost
was calculated by multiplying the total time spent
viewing the intervention by the mean hourly wage rate
for employed participants; the federal minimum wage
rate for retired subjects and a weighted average of the
mean hourly wage rate and the federal minimum wage
rate for participants with missing employment status.
The participant time cost for taking the follow-up
telephone survey was similarly calculated. Trans-
portation cost and the travel time cost to and from the
HIC was excluded from the analysis, as the study
subjects were going to the clinic to visit their primary
care physician for their wellness visit. 
IV. Cost-Effectiveness Analysis
A cost-effectiveness analysis was conducted to
identify the most efficient strategy for increasing CRCS
compliance compared to a survey-only control group
[20]. The incremental cost-effectiveness ratios (ICERs)
represent the additional cost per additional person
screened for CRC stepping up from the control group to
the web-based intervention group and then to the tailored
intervention group. ICER was computed by dividing the
incremental cost by the incremental effect. The
sensitivity of the incremental cost-effectiveness ratios
was assessed by tracking changes in the ICER with
changes in the assumptions regarding the overhead rate,
whether a “real world” program would include a follow-
up survey to assess the effect of the interventions on
screening behavior, and the assumption that the HIC
personnel would not be doing other tasks while patients
were going through the interactive computer and web
based interventions. The assumption of percent time
HIC personnel devoted to the intervention was varied
from 100% to 25%. In addition to the recruitment and
intervention cost, the base case scenario included the
follow-up survey cost and 35% overhead, the worst case
scenario included the follow-up survey cost and 40%
overhead and the best case scenario included no survey
cost and 30% overhead. Costs and effects were not
discounted because discounting would have little effect
over the one-year follow-up period.
104 Swati Misra, et al.
J Prev Med Public Health 2011;44(3):101-110
Table 1. Cost of intervention by activity
Program activity
Tailored
inter-
vention
cost ($)
Web-
based
inter-
vention
cost ($)
Step 1: Recruitment
(Identification of eligible participants from KRF
database, recruitment letter development
time cost- personnel, Recruitment letter
mailing time cost- personnel, enrollment
phone call)
Total recruitment time cost
Recruitment material cost for letter supplies
Total Step 1
Step 2: Intervention delivery
HIC visit time cost- personnel
Tailored program viewing time cost- 
participant
Web-based program viewing time cost-
participant
Total step 2
Step 3: Follow-up
6 month phone survey time cost-personnel
6 month phone survey time cost- participant
Total step 3
Total direct cost
Overhead: utilities, equipment, computers, 
database management, facility, office space.
Total overhead
Total cost ($)
Average cost per participant
Standard deviation of cost per participant
4728.85 
235.41
4964.26
5764.85
1946.35
0.0
7711.2
598.85
432.64
1031.49
13 726.28
4804.20
18 530.47
44.87
6.69
4557.10
226.86
4783.96
4548.32
0.0
1416.61
5964.93
577.10
413.58
990.68
11 739.57
4108.85
15 848.42
39.82
6.45
Table 2. Incremental cost effectiveness (cost per
additional individual screened)
Interven-
tion
Cost
($)
Incre-
mental
cost ($)
Effect
(%
screen-
ed)
Incre-
mental
effect
(%)
CE ($) ICER($)
Control
Web-based
Tailored
CE : cost-effectiveness, ICER : incremental cost-effectiveness ratio.
KRF: Kelsey research foundation, HIC: health information center.
0
39.82
44.87
-
39.82
5.05
0.3390
0.3543
0.3204
-
-0.0153
-0.0339
-
112
140
-
2602
Dominated
Cancer Screening Promotion      105
J Prev Med Public Health 2011;44(3):101-110
Statistical uncertainty in the cost and effect estimates
was assessed with nonparametric bootstrapping, a
method that requires no assumption of the sampling
distributions of the estimated cost or outcome [21].
Replicates of cost and effect were obtained and plotted
on the cost-effectiveness plane by sampling cost and
screening outcome for all the cases with replacement
one thousand times (see description in the appendix). 
The missing values of some direct cost variables were
imputed using simple linear regression models [22].The
screening compliance for each participant; a binary
variable, was obtained from the randomized trial. 
RESULTS
The study population was evenly distributed acrosss
the study groups About 80.0% of the patients were 50-
59 years old, 60.0% were female, 35.0% were white,
47.0% were African American, 12.5% were Hispanic
and 75.0% had a post high school level of education.
Over 90.0% of the patients had private insurance and
56.0% reported an income of over $50000 per year.
I. Costs and Cost-Effectiveness
Table 1 presents a breakdown of the cost per person
for administering the web-based educational intervention
and the tailored, interactive intervention.
The average cost was $39.82 and the standard
deviation was $6.45 per person for implementing the
web-based intervention. The average cost per person for
implementing the tailored intervention was $44.87 and
the standard deviation was $6.69 per person. Patients
were not randomized to intervention or control groups
until after they completed the baseline survey. Thus any
differences in costs to recruit people were not due to any
known/systematic differences between groups. The
variability in cost was primarily due to the time cost of
both patients and staff during the intervention delivery;
more time was required to complete the tailored
intervention. For the tailored intervention, about 56% of
the direct cost was for intervention delivery, compared to
51% for the web-based education intervention. The
remainder of direct cost was primarily for recruitment in
each intervention. Estimates of the base case incremental
cost-effectiveness analysis are presented in Table 2. 
Figure 2. ICER confidence intervals (CIs) with joint density of ΔC and ΔE  comparing  no intervention control
group to web-based intervention group in promoting CRCS.
ICER: incremental cost-effectiveness ratios, CRCS: cases of colorectal cancer screening.  
The screening compliance in the control group was
33.9% compared with 35.4% in the web-based group
and 32.0% in the tailored group. The randomized trial
did not yield statistically significant differences in
screening rates [13]. For the economic evaluation, the
point estimates represent the “best” available estimate of
program effects and costs. The mean ICER was $ 2602
moving from no intervention to the web-based
intervention, whereas the tailored intervention had a
negative mean ICER compared to both the control group
and the website intervention, due to negative effect. The
tailored intervention was dominated by the website
intervention as the tailored intervention was more costly
and less effective. Tables A1, A2 and A3 present the
results of the sensitivity analyses. The average cost and
the incremental cost effectiveness ratios showed
relatively small changes to alternative assumptions
regarding the inclusion of surveys and the overhead rate.
The ICER comparing the web-based intervention to the
control group declined by 30% when the percent time
the HIC personnel devoted to the intervention was
decreased from 100% to 25%. However, the cost per
additional person screened remained above $1800. 
II. Results of Uncertainty Analysis
The joint density of ΔC (difference in cost) and ΔE
(difference in effect) when comparing the survey-only
control group to the web-based intervention along with
the 95% confidence interval (CI) for ICER is
summarized in Figure 2. The joint density of ΔC and Δ
E when comparing the web-based intervention to the
tailored intervention along with the 95% CI for ICER is
summarized in Figure 3. 
The bootstrapped mean differences for cost and
effectiveness per participant presented in Figure 2 imply
that the web-based intervention has an added cost with a
positive effect compared with no intervention as 68.0%
of the bootstrapped replicates fall in the NE quadrant of
the cost effectiveness plane. Decision makers may
consider implementing this intervention depending on
how much they are willing to pay per additional person
screened for CRC and their assessment of the chance
that the intervention could result in lower screening
compliance than the no intervention alternative.
Implementing a tailored intervention compared to the
web-based education has a negative effect and an added
cost as most of the bootstrapped joint density for cost
and effect differences per participant fall in the NW
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Figure 3. ICER confidence intervals (CIs) with joint density of ΔC and ΔE  comparing  web-based intervention
group to tailored intervention in promoting CRCS.
ICER : incremental cost-effectiveness ratios, CRCS : cases of colorectal cancer screening. 
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quadrant of the CE plane. The results therefore do not
provide support for disseminating this type of tailored
intervention.
DISCUSSION
The results of this large, carefully executed trial of a
tailored intervention in a well-organized multi-specialty
group practice raise concerns about the efficiency of this
resource-intensive approach to CRCS promotion. The
tailored computer based intervention was dominated
(more costly and less effective) than a simpler web-
based education intervention. The web-based education
intervention was relatively costly compared to other mail
and system reminder based interventions in primary care
settings.
The results are consistent with the general findings
from a systematic review of patient directed tailored
intervention studies [23]. For example, Myers et al. [24]
found that implementation of targeted and tailored
interventions for CRCS promotion improved screening
compliance compared to regular care or no intervention.
However, the value of tailoring interventions was
questioned when compliance was shown to be slightly
lower than for the interventions involving mail and
telephone reminders. Ling et al. [25] presented results of
a randomized trial comparing tailored vs. non-tailored
physician recommendation letters and enhanced vs. non-
enhanced physician office and patient management
systems to improve screening rates for CRC in a
population of eligible patients aged 50-79 years in 10
primary care physician office practices in Philadelphia.
At one year follow-up, a flexible sigmoidoscopy or
colonoscopy was obtained by 54.2% of participants in
the non-tailored letter, enhanced management group,
53.3% in the tailored-letter, enhanced management
group, 43.6% in the tailored-letter, non- enhanced
management group and 37.6% in the non-tailored letter,
non-enhanced management group. Thus, in the
enhanced management group the tailored interventions
showed a smaller impact on CRCS compared to
providing non-tailored information on CRCS, similar to
our findings.
Our web-based intervention was less cost-effective
compared to previous studies of CRCS promotion. In a
study by Chirikos et al. [10] the authors presented results
of a low-cost inreach intervention to improve
mammography rates, FOBT compliance and pap testing
compliance in a low-income population of eligible
patients aged 50-75 years in a clinical setting. Cancer
screening office systems, a reminder system for
physicians to check the current screening status of
eligible patients and ensure completion of timely
screening, was implemented in primary care clinics in
Florida. The ICER results for an FOBT was $12 and the
compliance rate was 40% for the intervention group,
suggesting that the method of a non-computerized
reminder system utilizing the available clinic personnel
was cost effective for improving cancer screening
compliance in a primary care setting. However,
participants were low income and the control group
screening rate was 12%. Our participants were middle
class, insured, with a 30 percent screening rate in the
control group. A more recent study evaluated the cost-
effectiveness of an intervention among patients of a
multi-specialty group practice in eastern Massachusetts
[26]. The intervention included a tailored letter,
educational brochure, a fecal occult blood test kit with a
stamped return envelope, and a phone number to a
dedicated line for scheduling a sigmoidosopy or
colonoscopy. The baseline screening rate was 63%, the
increase in the screening rate was 5.8% and the
incremental cost per additional person screened was $94.
Costs may be low due to a fully operational electronic
medical record system, no mention of overhead costs,
and low cost for the FOBT kits. While letters were
tailored, there was no discussion of the degree or cost of
the tailoring. With multiple program elements, it was not
possible to determine the effectiveness of the tailoring
component.
The literature on cancer screening promotion supports
implementing some form of intervention, whether a
targeted intervention with mail or phone reminders or a
tailored intervention or generic print based information
about cancer screening to patients, or reminder systems
to physicians to positively affect screening compliance
among the target population of 50-70 years when
compared to no intervention [9-12,19,24,25].
However, our findings and those of studies described
above, raise questions about the information provided to
participants about CRCS. One possible explanation of
the limited effect of the interventions is that the baseline
survey about colorectal cancer and screening may have
cued the control group to action [27]. However, this
would not explain why the tailored intervention
performed worse than the web-based intervention.
Participants spent an average of 23 minutes on the
tailored intervention compared to 17 minutes on the
web-based program [13]. Perhaps, the more extensive
individualized information about cancer and screening
raises apprehension about screening, which could result
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in lower compliance. Also, the role of physicians is very
important for screening compliance [28]. Although the
physicians in the KSC group practice were informed
about the study and the importance of CRCS and
patients were encouraged to discuss CRCS with their
physician, including doctors more directly in the
intervention design may improve screening compliance.
A qualitative analysis of a subset of patients’ discussions
with providers about CRCS in the current study found
that providers focused on colonoscopy, which reduced
discussion of patient’s test preferences and conflicted
with our interventions’ focus on choice between multiple
test options [29].
Promoting CRCS via website interventions may be a
suitable strategy to improve screening rates compared to
similar print materials. However, the impact of the
website intervention on screening compliance was
minimal and the cost per additional person screened was
high compared to other studies. The recruitment cost
may be reduced with an automated system to determine
eligibility for screening. The study relied on staff making
multiple phone contacts to determine eligibility from a
list of potentially eligible patients. The research context
of the intervention contributed to the cost and therefore
the cost estimates represent an upper bound of feasible
cost in a practice setting. However, KSC was well
organized and had partially automated patient records
and appointment schedules that facilitated the study.
The interventions were tested in a single
multispecialty clinic thereby limiting the generalizability
of the results. Time estimates for the project personnel
were self-reported, but time logs were completed on a
weekly or monthly basis throughout the trial. Overhead
cost was calculated as a percent of the direct cost instead
of exact measurement. However, analysis of uncertainty
showed that a reasonable range of overhead costs had no
substantive effect on the overall findings. While the
randomized trial did not yield statistically significant
results, the point estimates along with an analysis of
uncertainty, provide valuable information for decision-
making, which is not about testing hypotheses but about
using the best available estimates of program effect and
cost to inform decisions about resource allocation [30]. 
More research is required to understand the cost and
the effectiveness of tailoring and other methods to
motivate patients to obtain recommended CRCS tests.
This requires an assessment of system, physician and
patient-centered efforts to educate patients and providers
and to address any perceived barriers to screening [28].
Costs should be fully assessed, including the cost of
planning and recruitment of eligible participants,
overhead costs, and the cost of developing information
for tailoring. 
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Table A3. Sensitivity analysis by varying the percentage of  HIC personnel cost
Intervention Cost ($) Incremental 
cost ($)
Effect
(% screened)
Incremental
effect (%) CE ($) ICER ($)
25% HIC cost 
Control
Web-based
Tailored
50% HIC cost
Control
Web-based
Tailored
75% HIC cost
Control
Web-based
Tailored
100% HIC cost
Control
Web-based
Tailored
HIC : health information center, ICER : incremental cost-effectiveness ratios, CE : cost-effectiveness.
0
28.25
30.74 
0
32.11
35.45
0
35.96
40.16
0
39.82
44.87
-
28.25
2.49
-
32.11
3.34
-
35.96
4.20
-
39.82
5.05
0.3390
0.3543
0.3204
0.3390
0.3543
0.3204
0.3390
0.3543
0.3204
0.3390
0.3543
0.3204
-
- 0.0153
- 0.0339
-
- 0.0153
- 0.0339
-
- 0.0153
- 0.0339
-
- 0.0153
- 0.0339
-
79.73
95.94
-
90.63
110.64
-
101.49
125.34
-
112.39
140.04
-
1846.40
Dominated
-
2098.69
Dominated
-
2350.33
Dominated
-
2602.6
Dominated
Appendix. Supplementary material
Bootstrapping using STATA was done in the following manner:
1. A “set seed” command was used for random number generation, which assured reproduction of results.
2. All 413 observations in the tailored computer intervention group and 398 observations in the web based intervention group were chosen to run the
bootstrapping and the number of replications was set to 1000.
3. Then bootstrapping was done using the following command:
4. Bs (location: mean=r(mean)), reps (1000) saving (Group 1, replace): summarize total cost, detail
5. Then, the difference in cost (ΔC) and difference in screening compliance (ΔE) were calculated by comparing control group bootstrapped data with
the web based intervention group and the tailored computer based intervention group.
6. Incremental cost effectiveness ratios were calculated using the expression ΔC/ΔE.
7. Scatter plot was produced by plotting the cost and effect difference pairs for tailored and control groups to show the distribution of incremental cost-
effectiveness ratios.  The same were done for web and control groups, and tailored and web groups. 
8. To calculate the 95% confidence limits, we identified 25 cases from the worst and best cases of ICERs. To draw 95% confidence limit lines on the
scatter plot, we identified the 26th case from both the worst and best cases of ICERs, and drew the lines by connecting 0 and (ΔC, ΔE).  The same
calculation was done for the base case (point estimate of ICER). This procedure was followed for the different intervention groups.
ICER : incremental cost-effectiveness ratios.
Table A1. Sensitivity analysis by varying inclusion of
surveys
Scenarios
Web-based
group 
average cost
($)
Web vs.
control 
ICER ($)
Base case (include 6 month 
survey cost)
Worst case (include 6 month and 
baseline survey costs)
Best case (exclude 6 month and  
baseline survey costs)
ICER : incremental cost-effectiveness ratios.
39.82 
42.89 
37.33
2602
2803
2439
Table A2. Sensitivity analysis by varying inclusion of
follow-up survey and overhead rate
Scenarios
Web-based
group 
average cost
($)
Web vs.
control 
ICER ($)
Base case ( include 6 month 
survey cost,  35% overhead)
Worst case (include 6 month 
survey cost, 40% overhead) 
Best case  (exclude 6 month 
survey cost, 30% overhead)
39.82
41.29 
35.11
2602
2698
2294
ICER : incremental cost-effectiveness ratios.
